Prophylactic mastectomy: Pros and cons

Patients to be considered for prophylactic mastectomy fall into two groups. The first group comprises those who have already had a mastectomy and are either contemplating reconstructive surgery or are concerned about the development of cancer in their remaining breast. Since the patient who has had...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1984-02, Vol.53 (S3), p.803-808
1. Verfasser: Snyderman, Reuven K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 808
container_issue S3
container_start_page 803
container_title Cancer
container_volume 53
creator Snyderman, Reuven K.
description Patients to be considered for prophylactic mastectomy fall into two groups. The first group comprises those who have already had a mastectomy and are either contemplating reconstructive surgery or are concerned about the development of cancer in their remaining breast. Since the patient who has had a mastectomy and is interested in reconstruction is already in a high‐risk group, she has discussed at the initial interview, the possibility of prophylactic mastectomy and reconstruction. The second group of patients considering a prophylactic mastectomy also fall into the high‐risk group. They have not yet had a mastectomy but find that they are emotionally disturbed by the constant finding of new masses, and many have also had a number of biopsies. The patients in the second group are usually referred by a physician or surgeon who has followed them for a long period of time, or they have come on their own because of their mental anguish. It is the second group of patients, especially, who need time to have discussed with them in detail all our current knowledge concerning their high‐risk status. However, both groups of patients must on their own, after counseling, make the final decision whether or not to have a prophylactic mastectomy.
doi_str_mv 10.1002/1097-0142(19840201)53:3+<803::AID-CNCR2820531332>3.0.CO;2-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80928221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80928221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4962-4e9c3e09ecddb8c8801dd0f560e05a0996b996ad06271d19d5ccb0fe4a7f54633</originalsourceid><addsrcrecordid>eNqNkF1LwzAYhYMoc05_grALGYp0vvlsM0UY9WswnIiC4EXIkhQr7TqbDdm_N2NzoBfiRd4QznkPJw9CKYYuBiBnGGQcAWbkGMuEAQF8wmmPnl4kQHu9_uAqSu_TR5IQ4BRTSi5pF7rp6JxEYgs1N9vbqAkAScQZfdlFe96_h2dMOG2ghhCSkFg2UeehrqZvi0KbWW7apfYzZ2ZVuei1g-DbemLbppr4fbST6cK7g_XdQs8310_pXTQc3Q7S_jAyTAoSMScNdSCdsXacmCQBbC1kXIADrkFKMQ5HWxAkxhZLy40ZQ-aYjjPOBKUt1FnlTuvqY-78TJW5N64o9MRVc68SkOHfBAfj68poQk1fu0xN67zU9UJhUEuKaslBLTmob4qKU0VVyAgjUFQ_KQYJVDpSRImQfriuMR-Xzm6y19iCfrTWtTe6yGo9Mbnf2CTHnDMWbG5l-8wLt_h3w2XBP_v9UugXHAyaKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80928221</pqid></control><display><type>article</type><title>Prophylactic mastectomy: Pros and cons</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Snyderman, Reuven K.</creator><creatorcontrib>Snyderman, Reuven K.</creatorcontrib><description>Patients to be considered for prophylactic mastectomy fall into two groups. The first group comprises those who have already had a mastectomy and are either contemplating reconstructive surgery or are concerned about the development of cancer in their remaining breast. Since the patient who has had a mastectomy and is interested in reconstruction is already in a high‐risk group, she has discussed at the initial interview, the possibility of prophylactic mastectomy and reconstruction. The second group of patients considering a prophylactic mastectomy also fall into the high‐risk group. They have not yet had a mastectomy but find that they are emotionally disturbed by the constant finding of new masses, and many have also had a number of biopsies. The patients in the second group are usually referred by a physician or surgeon who has followed them for a long period of time, or they have come on their own because of their mental anguish. It is the second group of patients, especially, who need time to have discussed with them in detail all our current knowledge concerning their high‐risk status. However, both groups of patients must on their own, after counseling, make the final decision whether or not to have a prophylactic mastectomy.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19840201)53:3+&lt;803::AID-CNCR2820531332&gt;3.0.CO;2-6</identifier><identifier>PMID: 6692279</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Age Factors ; Biological and medical sciences ; Biopsy ; Breast - pathology ; Breast - surgery ; Breast Neoplasms - pathology ; Breast Neoplasms - prevention &amp; control ; Computers ; Decision Making ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Mammary gland diseases ; Mastectomy - methods ; Medical sciences ; Middle Aged ; Prostheses and Implants ; Risk ; Tumors</subject><ispartof>Cancer, 1984-02, Vol.53 (S3), p.803-808</ispartof><rights>Copyright © 1984 American Cancer Society</rights><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4962-4e9c3e09ecddb8c8801dd0f560e05a0996b996ad06271d19d5ccb0fe4a7f54633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9515544$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6692279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Snyderman, Reuven K.</creatorcontrib><title>Prophylactic mastectomy: Pros and cons</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Patients to be considered for prophylactic mastectomy fall into two groups. The first group comprises those who have already had a mastectomy and are either contemplating reconstructive surgery or are concerned about the development of cancer in their remaining breast. Since the patient who has had a mastectomy and is interested in reconstruction is already in a high‐risk group, she has discussed at the initial interview, the possibility of prophylactic mastectomy and reconstruction. The second group of patients considering a prophylactic mastectomy also fall into the high‐risk group. They have not yet had a mastectomy but find that they are emotionally disturbed by the constant finding of new masses, and many have also had a number of biopsies. The patients in the second group are usually referred by a physician or surgeon who has followed them for a long period of time, or they have come on their own because of their mental anguish. It is the second group of patients, especially, who need time to have discussed with them in detail all our current knowledge concerning their high‐risk status. However, both groups of patients must on their own, after counseling, make the final decision whether or not to have a prophylactic mastectomy.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Breast - pathology</subject><subject>Breast - surgery</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - prevention &amp; control</subject><subject>Computers</subject><subject>Decision Making</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Mammary gland diseases</subject><subject>Mastectomy - methods</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prostheses and Implants</subject><subject>Risk</subject><subject>Tumors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1LwzAYhYMoc05_grALGYp0vvlsM0UY9WswnIiC4EXIkhQr7TqbDdm_N2NzoBfiRd4QznkPJw9CKYYuBiBnGGQcAWbkGMuEAQF8wmmPnl4kQHu9_uAqSu_TR5IQ4BRTSi5pF7rp6JxEYgs1N9vbqAkAScQZfdlFe96_h2dMOG2ghhCSkFg2UeehrqZvi0KbWW7apfYzZ2ZVuei1g-DbemLbppr4fbST6cK7g_XdQs8310_pXTQc3Q7S_jAyTAoSMScNdSCdsXacmCQBbC1kXIADrkFKMQ5HWxAkxhZLy40ZQ-aYjjPOBKUt1FnlTuvqY-78TJW5N64o9MRVc68SkOHfBAfj68poQk1fu0xN67zU9UJhUEuKaslBLTmob4qKU0VVyAgjUFQ_KQYJVDpSRImQfriuMR-Xzm6y19iCfrTWtTe6yGo9Mbnf2CTHnDMWbG5l-8wLt_h3w2XBP_v9UugXHAyaKQ</recordid><startdate>19840201</startdate><enddate>19840201</enddate><creator>Snyderman, Reuven K.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19840201</creationdate><title>Prophylactic mastectomy: Pros and cons</title><author>Snyderman, Reuven K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4962-4e9c3e09ecddb8c8801dd0f560e05a0996b996ad06271d19d5ccb0fe4a7f54633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Breast - pathology</topic><topic>Breast - surgery</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - prevention &amp; control</topic><topic>Computers</topic><topic>Decision Making</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Mammary gland diseases</topic><topic>Mastectomy - methods</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prostheses and Implants</topic><topic>Risk</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Snyderman, Reuven K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Snyderman, Reuven K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prophylactic mastectomy: Pros and cons</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1984-02-01</date><risdate>1984</risdate><volume>53</volume><issue>S3</issue><spage>803</spage><epage>808</epage><pages>803-808</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>Patients to be considered for prophylactic mastectomy fall into two groups. The first group comprises those who have already had a mastectomy and are either contemplating reconstructive surgery or are concerned about the development of cancer in their remaining breast. Since the patient who has had a mastectomy and is interested in reconstruction is already in a high‐risk group, she has discussed at the initial interview, the possibility of prophylactic mastectomy and reconstruction. The second group of patients considering a prophylactic mastectomy also fall into the high‐risk group. They have not yet had a mastectomy but find that they are emotionally disturbed by the constant finding of new masses, and many have also had a number of biopsies. The patients in the second group are usually referred by a physician or surgeon who has followed them for a long period of time, or they have come on their own because of their mental anguish. It is the second group of patients, especially, who need time to have discussed with them in detail all our current knowledge concerning their high‐risk status. However, both groups of patients must on their own, after counseling, make the final decision whether or not to have a prophylactic mastectomy.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>6692279</pmid><doi>10.1002/1097-0142(19840201)53:3+&lt;803::AID-CNCR2820531332&gt;3.0.CO;2-6</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1984-02, Vol.53 (S3), p.803-808
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_80928221
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Age Factors
Biological and medical sciences
Biopsy
Breast - pathology
Breast - surgery
Breast Neoplasms - pathology
Breast Neoplasms - prevention & control
Computers
Decision Making
Female
Gynecology. Andrology. Obstetrics
Humans
Mammary gland diseases
Mastectomy - methods
Medical sciences
Middle Aged
Prostheses and Implants
Risk
Tumors
title Prophylactic mastectomy: Pros and cons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T11%3A45%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prophylactic%20mastectomy:%20Pros%20and%20cons&rft.jtitle=Cancer&rft.au=Snyderman,%20Reuven%20K.&rft.date=1984-02-01&rft.volume=53&rft.issue=S3&rft.spage=803&rft.epage=808&rft.pages=803-808&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/1097-0142(19840201)53:3+%3C803::AID-CNCR2820531332%3E3.0.CO;2-6&rft_dat=%3Cproquest_cross%3E80928221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80928221&rft_id=info:pmid/6692279&rfr_iscdi=true